These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 34072320)

  • 1. Local Colonic Administration of a Serine Protease Inhibitor Improves Post-Inflammatory Visceral Hypersensitivity in Rats.
    Hanning N; De Bruyn M; Ceuleers H; Boogaerts T; Berg M; Smet A; De Schepper HU; Joossens J; van Nuijs ALN; De Man JG; Augustyns K; De Meester I; De Winter BY
    Pharmaceutics; 2021 May; 13(6):. PubMed ID: 34072320
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Effect of Serine Protease Inhibitors on Visceral Pain in Different Rodent Models With an Intestinal Insult.
    Ceuleers H; Hanning N; De Bruyn M; De Man JG; De Schepper HU; Li Q; Liu L; Abrams S; Smet A; Joossens J; Augustyns K; De Meester I; Pasricha PJ; De Winter BY
    Front Pharmacol; 2022; 13():765744. PubMed ID: 35721192
    [No Abstract]   [Full Text] [Related]  

  • 3. Newly developed serine protease inhibitors decrease visceral hypersensitivity in a post-inflammatory rat model for irritable bowel syndrome.
    Ceuleers H; Hanning N; Heirbaut J; Van Remoortel S; Joossens J; Van Der Veken P; Francque SM; De Bruyn M; Lambeir AM; De Man JG; Timmermans JP; Augustyns K; De Meester I; De Winter BY
    Br J Pharmacol; 2018 Sep; 175(17):3516-3533. PubMed ID: 29911328
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Protease Activated Receptor-2 Induces Immune Activation and Visceral Hypersensitivity in Post-infectious Irritable Bowel Syndrome Mice.
    Du L; Long Y; Kim JJ; Chen B; Zhu Y; Dai N
    Dig Dis Sci; 2019 Mar; 64(3):729-739. PubMed ID: 30446929
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Electroacupuncture Relieves Irritable Bowel Syndrome by Regulating IL-18 and Gut Microbial Dysbiosis in a Trinitrobenzene Sulfonic Acid-Induced Post-Inflammatory Animal Model.
    Song YF; Pei LX; Chen L; Geng H; Yuan MQ; Xu WL; Wu J; Zhou JY; Sun JH
    Am J Chin Med; 2020; 48(1):77-90. PubMed ID: 31918565
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prostaglandin E
    Grabauskas G; Wu X; Gao J; Li JY; Turgeon DK; Owyang C
    Gastroenterology; 2020 Jun; 158(8):2195-2207.e6. PubMed ID: 32084424
    [TBL] [Abstract][Full Text] [Related]  

  • 7. P2X3 receptors mediate visceral hypersensitivity during acute chemically-induced colitis and in the post-inflammatory phase via different mechanisms of sensitization.
    Deiteren A; van der Linden L; de Wit A; Ceuleers H; Buckinx R; Timmermans JP; Moreels TG; Pelckmans PA; De Man JG; De Winter BY
    PLoS One; 2015; 10(4):e0123810. PubMed ID: 25885345
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Altered vasoactive intestinal peptides expression in irritable bowel syndrome patients and rats with trinitrobenzene sulfonic acid-induced colitis.
    Del Valle-Pinero AY; Sherwin LB; Anderson EM; Caudle RM; Henderson WA
    World J Gastroenterol; 2015 Jan; 21(1):155-63. PubMed ID: 25574088
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Chronic colitis-induced visceral pain is associated with increased anxiety during quiescent phase.
    Salameh E; Meleine M; Gourcerol G; do Rego JC; do Rego JL; Legrand R; Breton J; Aziz M; Guérin C; Coëffier M; Savoye G; Marion-Letellier R
    Am J Physiol Gastrointest Liver Physiol; 2019 Jun; 316(6):G692-G700. PubMed ID: 30735453
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Olorinab (APD371), a peripherally acting, highly selective, full agonist of the cannabinoid receptor 2, reduces colitis-induced acute and chronic visceral hypersensitivity in rodents.
    Castro J; Garcia-Caraballo S; Maddern J; Schober G; Lumsden A; Harrington A; Schmiel S; Lindstrom B; Adams J; Brierley SM
    Pain; 2022 Jan; 163(1):e72-e86. PubMed ID: 33863856
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Colonic mucosal N-methyl-D-aspartate receptor mediated visceral hypersensitivity in a mouse model of irritable bowel syndrome.
    Qi QQ; Chen FX; Zhao DY; Li LX; Wang P; Li YQ; Zuo XL
    J Dig Dis; 2016 Jul; 17(7):448-57. PubMed ID: 27356126
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mechanisms contributing to visceral hypersensitivity: focus on splanchnic afferent nerve signaling.
    Deiteren A; De Man JG; Keating C; Jiang W; De Schepper HU; Pelckmans PA; Francque SM; De Winter BY
    Neurogastroenterol Motil; 2015 Dec; 27(12):1709-20. PubMed ID: 26337498
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Proteolytic Cleavage of Bioactive Peptides and Protease-Activated Receptors in Acute and Post-Colitis.
    De Bruyn M; Ceuleers H; Hanning N; Berg M; De Man JG; Hulpiau P; Hermans C; Stenman UH; Koistinen H; Lambeir AM; De Winter BY; De Meester I
    Int J Mol Sci; 2021 Oct; 22(19):. PubMed ID: 34639054
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Role for protease activity in visceral pain in irritable bowel syndrome.
    Cenac N; Andrews CN; Holzhausen M; Chapman K; Cottrell G; Andrade-Gordon P; Steinhoff M; Barbara G; Beck P; Bunnett NW; Sharkey KA; Ferraz JG; Shaffer E; Vergnolle N
    J Clin Invest; 2007 Mar; 117(3):636-47. PubMed ID: 17304351
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A pilot study of fecal serine-protease activity: a pathophysiologic factor in diarrhea-predominant irritable bowel syndrome.
    Róka R; Rosztóczy A; Leveque M; Izbéki F; Nagy F; Molnár T; Lonovics J; Garcia-Villar R; Fioramonti J; Wittmann T; Bueno L
    Clin Gastroenterol Hepatol; 2007 May; 5(5):550-5. PubMed ID: 17336590
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Elevated H2 O2 levels in trinitrobenzene sulfate-induced colitis rats contributes to visceral hyperalgesia through interaction with the transient receptor potential ankyrin 1 cation channel.
    Kogure Y; Wang S; Tanaka K; Hao Y; Yamamoto S; Nishiyama N; Noguchi K; Dai Y
    J Gastroenterol Hepatol; 2016 Jun; 31(6):1147-53. PubMed ID: 26574143
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Linaclotide inhibits colonic nociceptors and relieves abdominal pain via guanylate cyclase-C and extracellular cyclic guanosine 3',5'-monophosphate.
    Castro J; Harrington AM; Hughes PA; Martin CM; Ge P; Shea CM; Jin H; Jacobson S; Hannig G; Mann E; Cohen MB; MacDougall JE; Lavins BJ; Kurtz CB; Silos-Santiago I; Johnston JM; Currie MG; Blackshaw LA; Brierley SM
    Gastroenterology; 2013 Dec; 145(6):1334-46.e1-11. PubMed ID: 23958540
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Imipramine improves visceral sensation and gut barrier in rat models of irritable bowel syndrome.
    Nozu T; Miyagishi S; Ishioh M; Takakusaki K; Okumura T
    Eur J Pharmacol; 2020 Nov; 887():173565. PubMed ID: 32946869
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Quantification and Potential Functions of Endogenous Agonists of Transient Receptor Potential Channels in Patients With Irritable Bowel Syndrome.
    Cenac N; Bautzova T; Le Faouder P; Veldhuis NA; Poole DP; Rolland C; Bertrand J; Liedtke W; Dubourdeau M; Bertrand-Michel J; Zecchi L; Stanghellini V; Bunnett NW; Barbara G; Vergnolle N
    Gastroenterology; 2015 Aug; 149(2):433-44.e7. PubMed ID: 25911511
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Analgesic activity of cynaropicrinon on post-inflammatory irritable bowel syndrome visceral hypersensitivity in a rat model.
    Shi H; Zhu X; Cui Y; Qin Y; Yang L; Deng X
    Exp Ther Med; 2017 Nov; 14(5):4476-4482. PubMed ID: 29067122
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.